IP Pharmaceuticals' Incubator/Accelerator Round

IP Pharmaceuticals raised a round of funding on , . Investors include Advanced Science & Tech Commercialization Center.

IP Pharmaceuticals develops technologies and reagents for antiviral drug discovery focusing on therapeutics and vaccines to treat infectious diseases caused by viruses such as hepatitis, influenza, We…

Articles about IP Pharmaceuticals' Incubator/Accelerator Round: